2021
DOI: 10.1016/j.mimet.2021.106160
|View full text |Cite
|
Sign up to set email alerts
|

A rapid, antibiotic susceptibility test for multidrug-resistant, Gram-negative bacterial uropathogens using the biochemical assay, DETECT

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
13
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 12 publications
(13 citation statements)
references
References 53 publications
0
13
0
Order By: Relevance
“…The increasing prevalence of multidrug-resistant bacterial strains, particularly for the most common clinical pathogen P. aeruginosa in human isolates, presents a significant challenge in the identification of new treatment strategies, which can result in high rates of morbidity and mortality in hospitals and other healthcare facilities. Fortunately, a number of rapid methods have been developed to identify such MDR species and antibiotic susceptibility within a couple of hours from clinical isolates that have benefited from the reduction in increasing mortality [ 32 35 ]. Common characteristics for P. aeruginosa to represent the MDR behavior in clinical strains are the presence of drug resistance genes or its mutant variety in bacterial plasmid or in its genome, high expression of a β-lactamase group of enzymes, and up-regulation of drug efflux pump have been documented [ 36 39 ].…”
Section: Discussionmentioning
confidence: 99%
“…The increasing prevalence of multidrug-resistant bacterial strains, particularly for the most common clinical pathogen P. aeruginosa in human isolates, presents a significant challenge in the identification of new treatment strategies, which can result in high rates of morbidity and mortality in hospitals and other healthcare facilities. Fortunately, a number of rapid methods have been developed to identify such MDR species and antibiotic susceptibility within a couple of hours from clinical isolates that have benefited from the reduction in increasing mortality [ 32 35 ]. Common characteristics for P. aeruginosa to represent the MDR behavior in clinical strains are the presence of drug resistance genes or its mutant variety in bacterial plasmid or in its genome, high expression of a β-lactamase group of enzymes, and up-regulation of drug efflux pump have been documented [ 36 39 ].…”
Section: Discussionmentioning
confidence: 99%
“…The increasing incidence of MDR bacterial strains particularly for most common clinical pathogen P. aeruginosa in human isolates poses a significant challenge to identify new treatment strategies that can lead to high morbidity and mortality in hospitals. Fortunately, a number of rapid methods have been developed to identify such MDR species along with antibiotic susceptibility within a couple of hours from clinical isolates that have benefited to reduce increasing mortality [32][33][34][35].…”
Section: Discussionmentioning
confidence: 99%
“…One significant concern is the resistance of Enterobacteriaceae to later generations of cephalosporins due to the acquisition of plasmids encoding extended-spectrum β-lactamases (ESBLs) [3]. The treatment options for ESBL producing bacteria are limited as they confer resistance to many available antibiotics [4]. The most common of the ESBL variants is the CTX-M group of enzymes capable of hydrolyzing third-generation cephalosporins such as cefotaxime.…”
Section: Introductionmentioning
confidence: 99%